Centrient Acquires India’s Astral SteriTech

Expands Capabilities Into Sterile Injectable Antibiotics

 
• By Dave Wallace

Antibiotics specialist Centrient has struck a deal to acquire India’s Astral SteriTech in a move that will expand its portfolio to include sterile injectable finished-dose products.

Injectable Syringe Vial
The deal gives Centrient access to sterile injectable antibiotics • Source: Hurst Photo

More from Deals

More from Business